Discontinuation report ACT CELECOXIB
| Report ID | 123648 |
| Drug Identification Number | 02420155 |
| Brand name | ACT CELECOXIB |
| Common or Proper name | CELECOXIB 100MG CAPS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CELECOXIB |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | M01AH |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2021-02-28 |
| Actual discontinuation date | |
| Remaining supply date | 2021-02-28 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | TO BE DISC |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2020-09-03 | French | Compare |
| v1 | 2020-09-03 | English | Compare |
Showing 1 to 2 of 2